AL CAPITAL HOLDINGS 2016 LTD Inactive Instrument
AL Capital Holdings 2016 Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CPHO-M
IL0010843675
Pharmaceuticals
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 49.3 18.37K | Sales 2023 | 44.23 16.48K | Capitalization | 25.49M 9.5B |
|---|---|---|---|---|---|
| Net income 2022 | -48M -17.89B | Net income 2023 | -88M -32.8B | EV / Sales 2022 | 1,234,605 x |
| Net Debt 2022 | 17.5M 6.52B | Net Debt 2023 | 13.42M 5B | EV / Sales 2023 | 879,698 x |
| P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.67% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-14 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Tikun Olam Cannbit Pharmaceuticals Ltd, formerly Cannbit Pharmaceuticals Ltd, is an Israel-based company that produces medical cannabis. The Company engages in growing and cultivating medical cannabis products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +39.38% | 4.17B | |
| +121.46% | 2.33B | |
| +134.92% | 78.45M |
